Higher concentrations of plasma IL-23 were associated with NASH (p = 0.005), and higher concentrations of plasma IL-17A and lower concentrations of plasma IL-10 were associated with CHC (p = 0.001 and p = 0.016, respectively) in comparison with healthy controls. Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.